Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remark | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 345,188 |
Reported balance
After 2024-05-03 transaction · row 1
1 source rowRow 1 · 2024-05-03 · Sale · Disposed 798 · Balance 345,188 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 26, 2021 Filed Jul 28, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,679 | $115.39 | $539,917.76 |
DisclosureSEC source: 0001214659-21-007892 · marketforms-53475.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,921 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $115.10 to $115.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,659 | $114.68 | $1,337,057.62 |
DisclosureSEC source: 0001214659-21-007892 · marketforms-53475.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,600 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $114.10 to $115.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 20:32 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 288 | $117.34 | $33,793.92 |
DisclosureSEC source: 0001214659-21-007854 · marketforms-53388.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,259 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 23:28 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 242 | $131.48 | $31,818.16 |
DisclosureSEC source: 0001214659-21-007315 · marketforms-53257.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,547 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,629 | $117.30 | $191,077.46 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,789 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.13 to $117.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,024 | $116.62 | $702,493.58 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,418 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.13 to $117.08 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,003 | $115.50 | $231,343.90 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,442 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $115.00 to $115.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,878 | $114.54 | $444,183.41 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,445 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $114.00 to $114.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,130 | $113.37 | $241,485.98 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,323 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $112.96 to $113.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,836 | $112.63 | $206,784.82 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,453 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $111.95 to $112.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 900 | $111.59 | $100,426.50 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,289 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $110.89 to $111.80 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,200 | $110.20 | $132,237.00 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,189 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $109.86 to $110.52 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 400 | $108.98 | $43,590.00 |
DisclosureSEC source: 0001214659-21-006868 · marketforms-53172.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,389 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $108.70 to $109.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,776 | $98.54 | $175,014.32 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,789 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $98.15 to $98.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,191 | $97.23 | $310,245.61 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,565 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $96.89 to $97.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,155 | $96.30 | $400,122.35 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,756 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $95.88 to $96.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 9,253 | $95.47 | $883,381.13 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,911 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $94.88 to $95.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,900 | $94.15 | $178,893.93 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,164 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $93.63 to $94.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $97.75 | $65,981.25 |
DisclosureSEC source: 0001214659-21-005868 · marketforms-52898.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,064 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 473 | $141.84 | $67,088.76 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 11 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,739 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $141.65 to $142.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,486 | $140.96 | $632,358.22 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 10 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,212 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $140.55 to $141.52 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,545 | $140.09 | $216,444.92 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,698 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.53 to $140.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,393 | $138.78 | $193,319.29 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,243 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $138.47 to $139.17 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 766 | $137.79 | $105,547.60 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,636 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.46 to $138.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,138 | $136.87 | $429,492.10 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,402 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.43 to $137.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,020 | $135.86 | $410,290.56 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,540 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $135.39 to $136.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,257 | $134.84 | $304,344.26 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,560 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $134.39 to $135.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,400 | $133.64 | $187,094.04 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,817 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $133.35 to $133.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,400 | $132.40 | $185,356.08 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,217 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $132.02 to $132.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:26 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 201 | $133.12 | $26,757.12 |
DisclosureSEC source: 0001214659-21-004545 · marketforms-52361.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,617 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:31 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 169 | $122.20 | $20,651.80 |
DisclosureSEC source: 0001214659-21-003953 · ownership.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,818 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2021 Filed Apr 7, 2021 14:50 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 169 | $122.20 | $20,651.80 |
DisclosureSEC source: 0001214659-21-003998 · marketforms-52188.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,818 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 01, 2021 Filed Apr 7, 2021 14:45 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 169 | $122.20 | $20,651.80 |
DisclosureSEC source: 0001214659-21-003994 · marketforms-52188.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,818 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 100 | $138.45 | $13,844.50 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 12 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,987 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,358 | $137.80 | $187,132.81 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 11 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,087 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.38 to $138.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,608 | $136.63 | $219,693.80 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 10 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,445 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.22 to $137.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,361 | $135.53 | $319,983.50 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,053 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $135.19 to $136.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,765 | $134.87 | $238,049.08 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,414 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $134.18 to $135.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,267 | $133.70 | $169,393.85 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,179 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $133.13 to $134.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,402 | $132.53 | $318,328.41 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,446 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $132.08 to $133.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,729 | $131.68 | $359,343.26 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,848 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $131.07 to $132.06 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,896 | $130.49 | $247,410.94 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,577 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $129.96 to $130.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,761 | $129.15 | $227,427.69 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,473 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $128.78 to $129.66 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,353 | $128.20 | $173,457.71 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,234 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $127.68 to $128.68 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,400 | $127.23 | $178,122.98 |
DisclosureSEC source: 0001214659-21-003403 · marketforms-52059.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,587 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $126.67 to $127.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 700 | $150.52 | $105,366.03 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 13 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,987 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F14 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $150.46 to $150.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,100 | $149.81 | $464,420.92 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 12 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,687 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F13 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $149.41 to $150.40 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,760 | $148.68 | $410,369.77 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 11 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,787 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $148.31 to $149.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,974 | $147.77 | $734,986.59 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 10 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,547 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $147.23 to $148.23 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,177 | $146.91 | $466,717.82 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,521 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $146.20 to $147.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.